228 related articles for article (PubMed ID: 8380746)
1. Regional differences in the enhancement by GABA of [3H]zolpidem binding to omega 1 sites in rat brain membranes and sections.
Ruano D; Benavides J; Machado A; Vitorica J
Brain Res; 1993 Jan; 600(1):134-40. PubMed ID: 8380746
[TBL] [Abstract][Full Text] [Related]
2. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
Benavides J; Peny B; Ruano D; Vitorica J; Scatton B
Brain Res; 1993 Feb; 604(1-2):240-50. PubMed ID: 8096157
[TBL] [Abstract][Full Text] [Related]
3. Aging-associated changes in the pharmacological properties of the benzodiazepine (omega) receptor isotypes in the rat hippocampus.
Ruano D; Benavides J; Machado A; Vitorica J
J Neurochem; 1995 Feb; 64(2):867-73. PubMed ID: 7830081
[TBL] [Abstract][Full Text] [Related]
4. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem.
Dennis T; Dubois A; Benavides J; Scatton B
J Pharmacol Exp Ther; 1988 Oct; 247(1):309-22. PubMed ID: 2845057
[TBL] [Abstract][Full Text] [Related]
5. Synchronous postnatal increase in alpha1 and gamma2L GABA(A) receptor mRNAs and high affinity zolpidem binding across three regions of rat brain.
Roberts AA; Kellogg CK
Brain Res Dev Brain Res; 2000 Jan; 119(1):21-32. PubMed ID: 10648869
[TBL] [Abstract][Full Text] [Related]
6. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain.
Duncan GE; Knapp DJ; Breese GR; Crews FT; Little KY
Pharmacol Biochem Behav; 1998 Jun; 60(2):439-48. PubMed ID: 9632227
[TBL] [Abstract][Full Text] [Related]
7. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain.
Duncan GE; Breese GR; Criswell HE; McCown TJ; Herbert JS; Devaud LL; Morrow AL
Neuroscience; 1995 Feb; 64(4):1113-28. PubMed ID: 7753379
[TBL] [Abstract][Full Text] [Related]
8. [3H]zolpidem binding in alcohol-preferring and non-preferring rat brain.
Chen F; Rezvani A; Jarrott B; Lawrence AJ
Neurosci Lett; 1997 Dec; 238(3):103-6. PubMed ID: 9464630
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites.
Niddam R; Dubois A; Scatton B; Arbilla S; Langer SZ
J Neurochem; 1987 Sep; 49(3):890-9. PubMed ID: 3039057
[TBL] [Abstract][Full Text] [Related]
10. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
Lloyd GK; Danielou G; Thuret F
J Pharmacol Exp Ther; 1990 Nov; 255(2):690-6. PubMed ID: 2173755
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain.
Devaud LL; Morrow AL; Criswell HE; Breese GR; Duncan GE
Alcohol Clin Exp Res; 1995 Aug; 19(4):910-4. PubMed ID: 7485838
[TBL] [Abstract][Full Text] [Related]
12. High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors.
Arbilla S; Allen J; Wick A; Langer SZ
Eur J Pharmacol; 1986 Nov; 130(3):257-63. PubMed ID: 2878820
[TBL] [Abstract][Full Text] [Related]
13. Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites.
Squires RF; Ai J; Witt MR; Kahnberg P; Saederup E; Sterner O; Nielsen M
Neurochem Res; 1999 Dec; 24(12):1593-602. PubMed ID: 10591411
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of the GABA(A) receptor complex from brain regions of (hypoemotional) Roman high- and (hyperemotional) low-avoidance rats.
Bentareha R; Araujo F; Ruano D; Driscoll P; Escorihuela RM; Tobeña A; Fernández-Teruel A; Vitorica J
Eur J Pharmacol; 1998 Jul; 354(1):91-7. PubMed ID: 9726635
[TBL] [Abstract][Full Text] [Related]
15. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
Massotti M; Schlichting JL; Antonacci MD; Giusti P; Memo M; Costa E; Guidotti A
J Pharmacol Exp Ther; 1991 Mar; 256(3):1154-60. PubMed ID: 1848629
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the allosteric interaction between the gamma-aminobutyric acid (GABA) binding site and three different benzodiazepine binding sites of the GABAA/benzodiazepine receptor complex in the rat nervous system.
Ruano D; Vizuete M; Cano J; Machado A; Vitorica J
J Neurochem; 1992 Feb; 58(2):485-93. PubMed ID: 1309562
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.
McLeod M; Pralong D; Copolov D; Dean B
Brain Res Mol Brain Res; 2002 Aug; 104(2):203-9. PubMed ID: 12225875
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Benavides J; Peny B; Durand A; Arbilla S; Scatton B
J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419
[TBL] [Abstract][Full Text] [Related]
19. Absence of modifications of the pharmacological properties of the GABAA receptor complex during aging, as assessed in 3- and 24-month-old rat cerebral cortex.
Ruano D; Machado A; Vitorica J
Eur J Pharmacol; 1993 Jun; 246(1):81-7. PubMed ID: 8102608
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.
Arbilla S; Depoortere H; George P; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):248-51. PubMed ID: 2997631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
